Pharmac has approved funding for a new medicine with substantial health benefits for around 75,000 New Zealanders at high-risk of cardiovascular disease
There has been a high uptake by Māori and Pacific of new diabetes drugs under Pharmac’s first ethnicity-based funding criteria – a publicity campaign to encourage more uptake is to start soon
This month Pharmac – Te Pataka Whaioranga will launch a pioneering campaign, ‘You Are a Priority’, to raise awareness about the new funding criteria which enables Māori and Pacific people to get diabetes medicines more easily
A nearly-1900 signature petition is presented, calling for an urgent amendment to medicines legislation that limits nurse practitioners and pharmacist prescribers
Pharmac is working hard to ensure ongoing supply of a critical medicine used to treat RSV, following the outbreak of the respiratory virus in our communities
Pharmac is starting its funding assessment process for a new cystic fibrosis medication after receiving an application from pharmaceutical company Vertex
PHARMAC is considering declining 97 inactive medicine funding applications. Previously inactive applications have remained on PHARMAC’s books, despite being unlikely to be approved for funding. This has caused confusion as to if they will be funded and frustration at the lack of clarity
Epilepsy New Zealand chief executive Ross Smith says news of Pharmac being forced to look at switching funding to another anti-epilepsy drug “isn’t ideal”
Specialist GP Nikki Vadgama provides some tips to make your next paediatric eczema consult easier. She includes a review of new guidelines, resources, websites and medications for paediatric eczema management